Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554

Tickner, Zachary J.; Farzan, Michael

doi:10.3390/ph14121271

Open AccessCorrection

Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554

by

Zachary J. Tickner

^1,*

and

Michael Farzan

^1,2

¹

Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA

²

Emmune, Inc., Jupiter, FL 33458, USA

^*

Author to whom correspondence should be addressed.

Pharmaceuticals 2021, 14(12), 1271; https://doi.org/10.3390/ph14121271

Submission received: 8 September 2021 / Accepted: 5 November 2021 / Published: 6 December 2021

(This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps)

Download Versions Notes

Missing Citation

In the original article, Renzl, C.; Kakoti, A.; Mayer, G. Aptamer-Mediated Reversible Transactivation of Gene Expression by Light. Angew. Chem. Int. Ed. 2020, 59, 22414, doi:10.1002/anie.202009240 was not cited [1]. The citation has now been inserted in Section 2.8: Regulation of CRISPR-Cas Activity by Riboswitches, paragraph 2, and should read: A particularly interesting case was recently reported by Renzl et al., who incorporated aptamers to the photoreceptor PAL into gRNAs and demonstrated 546-fold regulation of mRNA levels in response to light in HeLa cells [190].

Reference

Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. [Google Scholar] [CrossRef] [PubMed]

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Tickner, Z.J.; Farzan, M. Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. Pharmaceuticals 2021, 14, 1271. https://doi.org/10.3390/ph14121271

AMA Style

Tickner ZJ, Farzan M. Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. Pharmaceuticals. 2021; 14(12):1271. https://doi.org/10.3390/ph14121271

Chicago/Turabian Style

Tickner, Zachary J., and Michael Farzan. 2021. "Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554" Pharmaceuticals 14, no. 12: 1271. https://doi.org/10.3390/ph14121271

APA Style

Tickner, Z. J., & Farzan, M. (2021). Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. Pharmaceuticals, 14(12), 1271. https://doi.org/10.3390/ph14121271

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554

Missing Citation

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI